Discover our latest insights, stories, and perspectives
A 3-year study of 3,966 adults found sustained brain health improvement at every age
A 2026 Finnish study found coffee drinkers had less visceral fat, more muscle, better glucose profiles, and distinct sex hormone patterns.
Dolly Parton's "rejoicing exercises" combined gospel music, shouting, and stretching
Lipfendra (enlicitide) is the first oral PCSK9 inhibitor, approved by the FDA in July 2026 at a list price of $315 a month.
B12 deficiency or low B12 levels have been estimated to affect about 40% of people over 60 years of age, and about 40% of the general population may be on the lower end of normal. Vitamin B12 deficiency can look like the signs and symptoms of diseases that are commonly associated with aging, such as...
Cutting meat and dairy for just a few weeks triggers measurable changes in metabolism, cholesterol regulation, and gene activity
A 2026 study found 98% of 113 personal care and cleaning products contained unlisted chemicals
Stanford researchers blocked a single aging protein to restore cartilage growth in joints.
Allergies…one of the most common presentations I see in clinical practice. From the mild to the serious, from food to dust, animal fur, and the ‘general unknown’. There are growing insights and evidence of the role gut microbes play in allergies. And, as we know, the microbiome plays a huge role in immune regulation –...
A 2026 study in Cell Host & Microbe found that saliva cancer prediction using oral microbiome analysis outperformed standard stool-based
Oregon's first legal psilocybin program tracked 346 participants for three months.
New 2026 AHA research on coffee heart health shows moderate coffee may lower risk of heart disease, stroke, AFib, and type 2 diabetes
